Sorafenib-induced reversible posterior leukoencephalopathy in patients with renal cell carcinoma: A report of two cases.

Furubayashi, Nobuki; Negishi, Takahito; Iwai, Hidenori; Nagase, Kei; Nakamura, Motonobu

Furubayashi, Nobuki; Negishi, Takahito; Iwai, Hidenori; Nagase, Kei; Nakamura, Motonobu.

Afiliación

Furubayashi N; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.
Negishi T; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.
Iwai H; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.
Nagase K; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.
Nakamura M; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan.

Mol Clin Oncol ; 7(2): 281-284, 2017 Aug.

Article en En | MEDLINE | ID: mdl-28781802

Palabras clave

magnetic resonance imaging; renal cell carcinoma; reversible posterior leukoencephalopathy; sorafenib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google